These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. High CSF neurofilament heavy chain levels in neuromyelitis optica. Miyazawa I; Nakashima I; Petzold A; Fujihara K; Sato S; Itoyama Y Neurology; 2007 Mar; 68(11):865-7. PubMed ID: 17353477 [TBL] [Abstract][Full Text] [Related]
43. Identification of potential biomarkers for neuromyelitis optica by quantitative proteomics. Ding Y; Chen Y; Sun J; Shi Y; Li G; Luan X; Wang S; Li X; Jiang W; Wang L; Zhang G Ann Clin Transl Neurol; 2024 May; 11(5):1184-1196. PubMed ID: 38425144 [TBL] [Abstract][Full Text] [Related]
44. Increased resistin levels in the serum and cerebrospinal fluid of patients with neuromyelitis optica. Qi Y; Jia K; Zhang DQ; Li T; Li LM; Zhang LJ; Wang J; Gao CL; Sun LS; Shi FD; Yang L Clin Chim Acta; 2016 May; 456():176-179. PubMed ID: 27000702 [TBL] [Abstract][Full Text] [Related]
46. Cerebrospinal fluid high-mobility group box protein 1 in neuromyelitis optica and multiple sclerosis. Wang H; Wang K; Wang C; Xu F; Zhong X; Qiu W; Hu X Neuroimmunomodulation; 2013; 20(2):113-8. PubMed ID: 23328212 [TBL] [Abstract][Full Text] [Related]
47. Cerebrospinal fluid α-synuclein levels are elevated in multiple sclerosis and neuromyelitis optica patients during replase. Wang H; Wang K; Xu W; Wang C; Qiu W; Zhong X; Dai Y; Wu A; Hu X J Neurochem; 2012 Jul; 122(1):19-23. PubMed ID: 22469018 [TBL] [Abstract][Full Text] [Related]
48. Increased plasma levels of epithelial neutrophil-activating peptide 78/CXCL5 during the remission of Neuromyelitis optica. Yang T; Wang S; Zheng Q; Wang L; Li Q; Wei M; Du Z; Fan Y BMC Neurol; 2016 Jul; 16():96. PubMed ID: 27401736 [TBL] [Abstract][Full Text] [Related]
49. Prediction of neuromyelitis optica attack severity by quantitation of complement-mediated injury to aquaporin-4-expressing cells. Hinson SR; McKeon A; Fryer JP; Apiwattanakul M; Lennon VA; Pittock SJ Arch Neurol; 2009 Sep; 66(9):1164-7. PubMed ID: 19752309 [TBL] [Abstract][Full Text] [Related]
50. Overlapping CNS inflammatory diseases: differentiating features of NMO and MS. Juryńczyk M; Craner M; Palace J J Neurol Neurosurg Psychiatry; 2015 Jan; 86(1):20-5. PubMed ID: 25248365 [TBL] [Abstract][Full Text] [Related]
51. Interleukin-17-secreting T cells in neuromyelitis optica and multiple sclerosis during relapse. Wang HH; Dai YQ; Qiu W; Lu ZQ; Peng FH; Wang YG; Bao J; Li Y; Hu XQ J Clin Neurosci; 2011 Oct; 18(10):1313-7. PubMed ID: 21795048 [TBL] [Abstract][Full Text] [Related]
52. Increased serum level of IL-37 in patients with multiple sclerosis and neuromyelitis optica. Farrokhi M; Rezaei A; Amani-Beni A; Etemadifar M; Kouchaki E; Zahedi A Acta Neurol Belg; 2015 Dec; 115(4):609-14. PubMed ID: 26008726 [TBL] [Abstract][Full Text] [Related]
53. Impaired regulatory function and enhanced intrathecal activation of B cells in neuromyelitis optica: distinct from multiple sclerosis. Quan C; Yu H; Qiao J; Xiao B; Zhao G; Wu Z; Li Z; Lu C Mult Scler; 2013 Mar; 19(3):289-98. PubMed ID: 22864301 [TBL] [Abstract][Full Text] [Related]
54. [Serum uric acid level and related clinical features in neuromyelitis optica]. You XF; Ye J; Qin W; Zhao WH; Hao YG; Hu WL Zhonghua Nei Ke Za Zhi; 2010 Nov; 49(11):935-8. PubMed ID: 21211206 [TBL] [Abstract][Full Text] [Related]
55. Elevated soluble syndecan-1 levels in neuromyelitis optica are associated with disease severity. Pei S; Zheng D; Wang Z; Hu X; Pan S; Wang H Cytokine; 2018 Nov; 111():140-145. PubMed ID: 30142535 [TBL] [Abstract][Full Text] [Related]
57. A systematic analysis of the complement pathways in patients with neuromyelitis optica indicates alteration but no activation during remission. Veszeli N; Füst G; Csuka D; Trauninger A; Bors L; Rozsa C; Nagy Z; Jobbágy Z; Eizler K; Prohászka Z; Varga L; Illes Z Mol Immunol; 2014 Feb; 57(2):200-9. PubMed ID: 24172223 [TBL] [Abstract][Full Text] [Related]
58. Cerebrospinal fluid BAFF and APRIL levels in neuromyelitis optica and multiple sclerosis patients during relapse. Wang H; Wang K; Zhong X; Qiu W; Dai Y; Wu A; Hu X J Clin Immunol; 2012 Oct; 32(5):1007-11. PubMed ID: 22644841 [TBL] [Abstract][Full Text] [Related]
59. Antiacquaporin 4 antibodies detection by different techniques in neuromyelitis optica patients. Fazio R; Malosio ML; Lampasona V; De Feo D; Privitera D; Marnetto F; Centonze D; Ghezzi A; Comi G; Furlan R; Martino G Mult Scler; 2009 Oct; 15(10):1153-63. PubMed ID: 19667009 [TBL] [Abstract][Full Text] [Related]
60. [Evaluation of diagnostic value for NMO-IgG in patients with neuromyelitis optica]. Yang Y; Huang DH; Wu L; Wu WP Zhonghua Yi Xue Za Zhi; 2010 Mar; 90(9):606-9. PubMed ID: 20450783 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]